National Pharmaceutical Pricing Authority (NPPA) NPPA fixes the price of 81 medicines including off-patent anti-diabetic drugs allowing due benefits of patent expiry to the patients.
NPPA in its meeting on March 10, decided to regulate the price of these formulations as per provisions of DPCO, 2013 as the exemption period has been over. Now, these medicines have become more affordable to the public.
NPPA also fixed retail price of 76 new drugs to be launched by existing manufacturers including off-patent Anti-diabetic drugs allowing due benefit of patent expiry to the patients.
Revision in existing ceiling prices of scheduled formulations based on the Wholesale Price Index (WPI) was also approved by the Authority. The revised prices will be effective from April, 2021.
